Concepedia

Mark A. Behlke

MA

Statistics

Publications

131

Citations

13.7K

H-Index

59

Active since

1985

Affiliations

Integrated DNA Technologies (United States)(Current)

University of Iowa

Howard Hughes Medical Institute

Monash University

Monash Institute of Medical Research

Mark A. Behlke is an author at Integrated DNA Technologies (United States) specializing in medicine, cell biology, and gene expression.

ORCID

Top concepts

Publications per year

1985–2023

131

Publications

131

Identification of preexisting adaptive immunity to Cas9 proteins in humans

Carsten T. Charlesworth, Priyanka S. Deshpande, Daniel P. Dever et al. · Nature Medicine · 2019 · 924 citations · Full text

, , +10

A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells

Christopher A. Vakulskas, Daniel P. Dever, Garrett R. Rettig et al. · Nature Medicine · 2018 · 771 citations · Full text

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

Daniel Rosenblum, Anna Gutkin, Ranit Kedmi et al. · Science Advances · 2020 · 541 citations · Full text

Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins

Rolen M. Quadros, Hiromi Miura, Donald W. Harms et al. · Genome biology · 2017 · 539 citations · Full text

Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides

Kim A. Lennox, Mark A. Behlke · Nucleic Acids Research · 2015 · 449 citations · Full text

, , +15

1–5 of 131